BIO-Europe 2007 to Tackle Most Urgent Issues Arising From Convergence of Biotech and Pharma

CARLSBAD, Calif. and MUNICH, Germany--(BUSINESS WIRE)--The leaders of the biotechnology industry will once again gather for BIO-Europe, the world’s largest stand-alone partnering conference, in Hamburg, Germany (November 12-14). This year’s edition promises to set a new standard for compelling and informative content necessary to discern opportunities in an era of significant biotech industry change. Join many of the most respected thought leaders and decision makers in the industry and examine the issues, new business approaches and policy trends most important to the emerging biotech future.

A central theme to BIO-Europe 2007 will be to understand the signs, symptoms and opportunities of the much-anticipated convergence of biotech and Big Pharma. Fundamental questions, such as how can biotechnology companies help the pharmaceutical industry meet double digit growth expectations by contributing new products and processes, will be openly discussed and debated by some of the most notable names in the industry. A session destined to shake up traditional wisdom and preconceived notions of the industry is entitled, “The Changing World Order of Biotech-Pharma – How Will Emerging Realities Affect Your Business Strategy?"

Other conference highlights include the not to be missed 5th annual “A Day in the Life of Experienced Dealmakers” Plenary Session. Led by James Watson, Managing Director and Head of Merchant Banking, Burrill & Company and including industry notables as Thomas Hofstaetter, Senior Vice President of Corporate Development, Wyeth and John G. Goddard, Global Head and Senior VP of Strategic Planning and Business Development, AstraZeneca, this highly popular and provocative forum promises to continue its tradition of lively and insightful debate over key issues of strategic deal making by some of the biggest names in biotech deal making.

Notes to Editors:

Entry to BIO-Europe 2007 is free to the media, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe conference website at http://www.ebdgroup.com/bioeurope for detailed information on this year’s conference and online registration. When you register online, please indicate in the comment field that you are requesting a complimentary press registration. Please fax a copy of your press pass to complete your complimentary media registration to fax number +49 (89) 23 88 756 - 55.

About BIO-Europe 2007

BIO-Europe 2007 is the preeminent partnering conference for the biotechnology industry. Delegates from all parts of the biotechnology value-chain come to BIO-Europe to efficiently identify, engage and enter into the strategic relationships that drive their business successfully forward. It is anticipated that this year’s BIO-Europe partnering event will draw 2,000 industry attendees from almost 40 countries, representing over 1,000 companies for three days of high-level networking. BIO-Europe features the industry’s most advanced Web based partnering system that delegates will use to generate in excess of 7,000 partnering meetings. BIO-Europe features an exceptional international exhibition where companies, organizations and biotech regions can showcase their offerings. Additional networking opportunities will abound at evening and special events.

About EBD Group

EBD Group is the leading partnering firm for the global biotechnology industry. Since 1993, firms in the life sciences have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business.

EBD Group’s conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, the world’s largest stand-alone life science partnering conference; BIO-Europe Spring; the investor conference, BioEquity Europe (co-organized with BioCentury Publications); and the convergent medical technology partnering conference, BioDevice Partnering. EBD’s novel, web-based, partnering software system is also used at numerous third-party events around the world. Outside of the conference format, EBD Group’s consultants can provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in San Diego, Munich and London. For more information visit www.ebdgroup.com